Disposition of 201 shares by Grant Sean of Vera Therapeutics at 38.231 subject to Rule 16b-3
VERA Stock | USD 48.31 1.28 2.72% |
About 58% of Vera Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Vera Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Vera Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Vera Therapeutics stock news signals to limit their universe of possible portfolio assets.
Vera |
Filed transaction by Vera Therapeutics Officer Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Vera Therapeutics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Vera Therapeutics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Vera Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Vera Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Vera Therapeutics Historical Investor Sentiment
Investor biases related to Vera Therapeutics' public news can be used to forecast risks associated with an investment in Vera. The trend in average sentiment can be used to explain how an investor holding Vera can time the market purely based on public headlines and social activities around Vera Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Vera Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Vera Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Vera Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Vera Therapeutics.
Vera Therapeutics Fundamental Analysis
We analyze Vera Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vera Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vera Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Vera Therapeutics is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Vera Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vera Therapeutics stock to make a market-neutral strategy. Peer analysis of Vera Therapeutics could also be used in its relative valuation, which is a method of valuing Vera Therapeutics by comparing valuation metrics with similar companies.
Peers
Vera Therapeutics Related Equities
THRD | Third Harmonic | 8.91 | ||||
VTYX | Ventyx Biosciences | 6.94 | ||||
MLYS | Mineralys Therapeutics, | 5.22 | ||||
ANAB | AnaptysBio | 5.20 | ||||
ETON | Eton Pharmaceuticals | 4.47 | ||||
TARS | Tarsus Pharmaceuticals | 3.97 | ||||
TYRA | Tyra Biosciences | 3.06 | ||||
RLYB | Rallybio Corp | 3.03 | ||||
CYTK | Cytokinetics | 3.00 | ||||
RAPT | RAPT Therapeutics | 2.86 | ||||
CGEM | Cullinan Oncology | 2.62 | ||||
ACRV | Acrivon Therapeutics, | 1.71 | ||||
GLUE | Monte Rosa | 1.68 | ||||
COGT | Cogent Biosciences | 1.67 | ||||
CNTB | Connect Biopharma | 1.01 | ||||
ALDX | Aldeyra | 0.83 | ||||
EWTX | Edgewise Therapeutics | 0.69 | ||||
TVTX | Travere Therapeutics | 0.05 | ||||
ANEB | Anebulo Pharmaceuticals | 2.67 | ||||
ADAG | Adagene | 3.10 | ||||
XLO | Xilio Development | 3.26 |
Complementary Tools for Vera Stock analysis
When running Vera Therapeutics' price analysis, check to measure Vera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vera Therapeutics is operating at the current time. Most of Vera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vera Therapeutics' price. Additionally, you may evaluate how the addition of Vera Therapeutics to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |